------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Xinhua News Agency, Beijing, January 16th, by reporter Ye Yuan

Treebanked sentence:
--------------------
    Xinhua News Agency , Beijing , January 16th , by reporter Ye Yuan

Tree:
-----
    (TOP (FRAG-HLN (NP (NNP Xinhua)
                       (NNP News)
                       (NNP Agency))
                   (, ,)
                   (NP-LOC (NNP Beijing))
                   (, ,)
                   (NP-TMP (NNP January)
                           (NN 16th))
                   (, ,)
                   (PP (IN by)
                       (NP (NN reporter)
                           (NNP Ye)
                           (NNP Yuan)))))

Leaves:
-------
    0   Xinhua
           name:  ORG                0-2    Xinhua News Agency
    1   News
    2   Agency
    3   ,
    4   Beijing
           name:  GPE                4-4    Beijing
    5   ,
    6   January
           name:  DATE               6-7    January 16th
    7   16th
    8   ,
    9   by
    10  reporter
    11  Ye
        !  name:  PERSON             11-12  Ye Yuan
    12  Yuan


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    China's pharmaceutical enterprises, which mainly produce large amount of medicines used as raw materials and imitate
    foreign chemical medicines over a long period of time, will accelerate the development of new medicines and technologies
    with their own intellectual property rights.

Treebanked sentence:
--------------------
    China 's pharmaceutical enterprises , which *T*-10 mainly produce large amount of medicines used * as raw materials and
    imitate foreign chemical medicines over a long period of time , will accelerate the development of new medicines and
    technologies with their own intellectual property rights .

Tree:
-----
    (TOP (S (NP-SBJ (NP (NP (NNP China)
                            (POS 's))
                        (JJ pharmaceutical)
                        (NNS enterprises))
                    (SBAR (, ,)
                          (WHNP-10 (WDT which))
                          (S (NP-SBJ (-NONE- *T*-10))
                             (ADVP (RB mainly))
                             (VP (VP (VBP produce)
                                     (NP (NP (JJ large)
                                             (NN amount))
                                         (PP (IN of)
                                             (NP (NP (NNS medicines))
                                                 (VP (VBN used)
                                                     (NP (-NONE- *))
                                                     (PP-CLR (IN as)
                                                             (NP (JJ raw)
                                                                 (NNS materials))))))))
                                 (CC and)
                                 (VP (VBP imitate)
                                     (NP (JJ foreign)
                                         (JJ chemical)
                                         (NNS medicines))
                                     (PP-TMP (IN over)
                                             (NP (NP (DT a)
                                                     (JJ long)
                                                     (NN period))
                                                 (PP (IN of)
                                                     (NP (NN time))))))))
                          (, ,)))
            (VP (MD will)
                (VP (VB accelerate)
                    (NP (NP (DT the)
                            (NN development))
                        (PP (IN of)
                            (NP (JJ new)
                                (NNS medicines)
                                (CC and)
                                (NNS technologies))))
                    (PP (IN with)
                        (NP (PRP$ their)
                            (JJ own)
                            (NML (JJ intellectual)
                                 (NN property))
                            (NNS rights)))))
            (. .)))

Leaves:
-------
    0   China
           coref: IDENT        20996 0-1    China 's
           coref: IDENT        20995 0-3    China 's pharmaceutical enterprises
           name:  GPE                0-0    China
    1   's
    2   pharmaceutical
    3   enterprises
    4   ,
    5   which
    6   *T*-10
    7   mainly
    8   produce
           sense: produce-v.1
           prop:  produce.01
            v          * -> 8:0,  produce
            ARG0       * -> 6:0,  *T*-10 -> 5:1, which
            ARGM-ADV   * -> 7:1,  mainly
            ARG1       * -> 9:2,  large amount of medicines used * as raw materials
            LINK-SLC   * -> 0:2,  China 's pharmaceutical enterprises
                       * -> 6:0,  *T*-10 -> 5:1, which
    9   large
    10  amount
           sense: amount-n.1
    11  of
    12  medicines
           sense: medicine-n.1
    13  used
           sense: use-v.1
           prop:  use.01
            v          * -> 13:0, used
            ARG1       * -> 14:0, *
            ARG2       * -> 15:1, as raw materials
            LINK-PCR   * -> 12:1, medicines
                       * -> 14:0, *
    14  *
    15  as
    16  raw
    17  materials
           sense: material-n.2
    18  and
    19  imitate
           sense: imitate-v.2
           prop:  imitate.01
            v          * -> 19:0, imitate
            ARG0       * -> 6:0,  *T*-10 -> 5:1, which
            ARGM-ADV   * -> 7:1,  mainly
            ARG1       * -> 20:1, foreign chemical medicines
            ARGM-TMP   * -> 23:1, over a long period of time
            LINK-SLC   * -> 0:2,  China 's pharmaceutical enterprises
                       * -> 6:0,  *T*-10 -> 5:1, which
    20  foreign
    21  chemical
    22  medicines
           sense: medicine-n.1
    23  over
    24  a
    25  long
    26  period
    27  of
    28  time
           sense: time-n.2
    29  ,
    30  will
    31  accelerate
           sense: accelerate-v.1
           prop:  accelerate.01
            v          * -> 31:0, accelerate
            ARG0       * -> 0:3,  China 's pharmaceutical enterprises , which *T*-10 mainly produce large amount of
                                  medicines used * as raw materials and imitate foreign chemical medicines over a long
                                  period of time ,
            ARGM-MOD   * -> 30:0, will
            ARG1       * -> 32:2, the development of new medicines and technologies
            ARGM-MNR   * -> 39:1, with their own intellectual property rights
    32  the
    33  development
    34  of
    35  new
    36  medicines
           sense: medicine-n.1
    37  and
    38  technologies
           sense: technology-n.1
    39  with
    40  their
           coref: IDENT        20995 40-40  their
    41  own
    42  intellectual
    43  property
           sense: property-n.2
    44  rights
    45  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    An official from the State Pharmaceutical Administration Bureau said that, starting this year, financial aid for the
    research of innovative medicines will be further increased, and State-owned funds would give investment priority to the
    fields of high technology and innovated medical products.

Treebanked sentence:
--------------------
    An official from the State Pharmaceutical Administration Bureau said that , *PRO* starting this year , financial aid for
    the research of innovative medicines will be further increased *-11 , and State - owned funds would give investment
    priority to the fields of high technology and innovated medical products .

Tree:
-----
    (TOP (S (NP-SBJ (NP (DT An)
                        (NN official))
                    (PP (IN from)
                        (NP (DT the)
                            (NNP State)
                            (NML (NNP Pharmaceutical)
                                 (NNP Administration))
                            (NNP Bureau))))
            (VP (VBD said)
                (SBAR (IN that)
                      (S (S (S-ADV (, ,)
                                   (NP-SBJ (-NONE- *PRO*))
                                   (VP (VBG starting)
                                       (NP-TMP (DT this)
                                               (NN year)))
                                   (, ,))
                            (NP-SBJ-11 (NP (JJ financial)
                                           (NN aid))
                                       (PP (IN for)
                                           (NP (NP (DT the)
                                                   (NN research))
                                               (PP (IN of)
                                                   (NP (JJ innovative)
                                                       (NNS medicines))))))
                            (VP (MD will)
                                (VP (VB be)
                                    (ADVP (RB further))
                                    (VP (VBN increased)
                                        (NP (-NONE- *-11))))))
                         (, ,)
                         (CC and)
                         (S (NP-SBJ (ADJP (NN State)
                                          (HYPH -)
                                          (VBN owned))
                                    (NNS funds))
                            (VP (MD would)
                                (VP (VB give)
                                    (NP (NN investment)
                                        (NN priority))
                                    (PP-DTV (IN to)
                                            (NP (NP (DT the)
                                                    (NNS fields))
                                                (PP (IN of)
                                                    (NP (NP (JJ high)
                                                            (NN technology))
                                                        (CC and)
                                                        (NP (VBN innovated)
                                                            (JJ medical)
                                                            (NNS products))))))))))))
            (. .)))

Leaves:
-------
    0   An
           coref: IDENT        21012 0-7    An official from the State Pharmaceutical Administration Bureau
    1   official
           sense: official-n.1
    2   from
    3   the
           coref: IDENT        21014 3-7    the State Pharmaceutical Administration Bureau
           name:  ORG                3-7    the State Pharmaceutical Administration Bureau
    4   State
    5   Pharmaceutical
    6   Administration
    7   Bureau
    8   said
           sense: say-v.1
           prop:  say.01
            v          * -> 8:0,  said
            ARG0       * -> 0:2,  An official from the State Pharmaceutical Administration Bureau
            ARG1       * -> 9:1,  that , *PRO* starting this year , financial aid for the research of innovative
                                  medicines will be further increased *-11 , and State - owned funds would give
                                  investment priority to the fields of high technology and innovated medical products
    9   that
    10  ,
    11  *PRO*
    12  starting
           sense: start-v.1
           prop:  start.01
            v          * -> 12:0, starting
            ARG1       * -> 11:0, *PRO*
            ARGM-TMP   * -> 13:1, this year
    13  this
           coref: IDENT        21016 13-14  this year
           name:  DATE               13-14  this year
    14  year
    15  ,
    16  financial
    17  aid
           sense: aid-n.3
           prop:  aid.01
            n          * -> 17:0, aid
            ARGM-MNR   * -> 16:0, financial
            ARG2       * -> 18:1, for the research of innovative medicines
    18  for
    19  the
    20  research
           sense: research-n.1
    21  of
    22  innovative
    23  medicines
           sense: medicine-n.1
    24  will
    25  be
    26  further
    27  increased
           sense: increase-v.1
           prop:  increase.01
            v          * -> 27:0, increased
            ARGM-TMP   * -> 10:1, , *PRO* starting this year ,
            ARGM-MOD   * -> 24:0, will
            ARGM-EXT   * -> 26:1, further
            ARG1       * -> 28:0, *-11 -> 16:2, financial aid for the research of innovative medicines
            LINK-PCR   * -> 28:0, *-11 -> 16:2, financial aid for the research of innovative medicines
                       * -> 28:0, *-11 -> 16:2, financial aid for the research of innovative medicines
    28  *-11
    29  ,
    30  and
    31  State
           sense: state-n.2
           name:  ORG                31-31  State
    32  -
    33  owned
           prop:  own.01
            v          * -> 33:0, owned
            ARG0       * -> 31:0, State
            ARG1       * -> 34:0, funds
    34  funds
           sense: fund-n.2
    35  would
    36  give
           sense: give-v.3
           prop:  give.01
            v          * -> 36:0, give
            ARG0       * -> 31:2, State - owned funds
            ARGM-MOD   * -> 35:0, would
            ARG1       * -> 37:1, investment priority
            ARG2       * -> 39:1, to the fields of high technology and innovated medical products
    37  investment
           sense: investment-n.3
    38  priority
           sense: priority-n.2
    39  to
    40  the
    41  fields
           sense: field-n.3
    42  of
    43  high
    44  technology
           sense: technology-n.1
    45  and
    46  innovated
           prop:  innovate.01
            v          * -> 46:0, innovated
            ARG1       * -> 47:0, medical
                         -> 48:0, products
    47  medical
    48  products
           sense: product-n.1
    49  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    This year, the State Pharmaceutical Administration Bureau will evaluate and decide the top 50 enterprises in the
    pharmaceutical industry according to new criteria.

Treebanked sentence:
--------------------
    This year , the State Pharmaceutical Administration Bureau will evaluate and decide the top 50 enterprises in the
    pharmaceutical industry according to new criteria .

Tree:
-----
    (TOP (S (NP-TMP (DT This)
                    (NN year))
            (, ,)
            (NP-SBJ (DT the)
                    (NNP State)
                    (NML (NNP Pharmaceutical)
                         (NNP Administration))
                    (NNP Bureau))
            (VP (MD will)
                (VP (VB evaluate)
                    (CC and)
                    (VB decide)
                    (NP (DT the)
                        (JJ top)
                        (CD 50)
                        (NNS enterprises))
                    (PP-LOC (IN in)
                            (NP (DT the)
                                (JJ pharmaceutical)
                                (NN industry)))
                    (PP (VBG according)
                        (PP (IN to)
                            (NP (JJ new)
                                (NNS criteria))))))
            (. .)))

Leaves:
-------
    0   This
           coref: IDENT        21016 0-1    This year
           name:  DATE               0-1    This year
    1   year
    2   ,
    3   the
           coref: IDENT        21014 3-7    the State Pharmaceutical Administration Bureau
           name:  ORG                3-7    the State Pharmaceutical Administration Bureau
    4   State
    5   Pharmaceutical
    6   Administration
    7   Bureau
    8   will
    9   evaluate
           sense: evaluate-v.1
           prop:  evaluate.01
            v          * -> 9:0,  evaluate
            ARGM-TMP   * -> 0:1,  This year
            ARG0       * -> 3:1,  the State Pharmaceutical Administration Bureau
            ARGM-MOD   * -> 8:0,  will
            ARG1       * -> 12:1, the top 50 enterprises
            ARGM-LOC   * -> 16:1, in the pharmaceutical industry
            ARGM-ADV   * -> 20:1, according to new criteria
    10  and
    11  decide
           sense: decide-v.1
           prop:  decide.01
            v          * -> 11:0, decide
            ARGM-TMP   * -> 0:1,  This year
            ARG0       * -> 3:1,  the State Pharmaceutical Administration Bureau
            ARGM-MOD   * -> 8:0,  will
            ARG1       * -> 12:1, the top 50 enterprises
            ARGM-LOC   * -> 16:1, in the pharmaceutical industry
            ARGM-ADV   * -> 20:1, according to new criteria
    12  the
    13  top
    14  50
           name:  CARDINAL           14-14  50
    15  enterprises
    16  in
    17  the
    18  pharmaceutical
    19  industry
           sense: industry-n.1
    20  according
    21  to
    22  new
    23  criteria
    24  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Total annual sales revenue is predicted to be more than 60 % of the whole country's medicine sales revenue.

Treebanked sentence:
--------------------
    Total annual sales revenue is predicted *-12 to be more than 60 % of the whole country 's medicine sales revenue .

Tree:
-----
    (TOP (S (NP-SBJ-12 (JJ Total)
                       (JJ annual)
                       (NNS sales)
                       (NN revenue))
            (VP (VBZ is)
                (VP (VBN predicted)
                    (S (NP-SBJ (-NONE- *-12))
                       (VP (TO to)
                           (VP (VB be)
                               (NP-PRD (NP (QP (JJR more)
                                               (IN than)
                                               (CD 60))
                                           (NN %))
                                       (PP (IN of)
                                           (NP (NP (DT the)
                                                   (JJ whole)
                                                   (NN country)
                                                   (POS 's))
                                               (NML (NN medicine)
                                                    (NNS sales))
                                               (NN revenue)))))))))
            (. .)))

Leaves:
-------
    0   Total
    1   annual
    2   sales
           sense: sale-n.1
    3   revenue
           sense: revenue-n.1
    4   is
    5   predicted
           prop:  predict.01
            v          * -> 5:0,  predicted
            ARG1       * -> 0:1,  Total annual sales revenue
                         -> 6:2,  *-12 to be more than 60 % of the whole country 's medicine sales revenue
    6   *-12
    7   to
    8   be
           sense: be-v.1
    9   more
           name:  PERCENT            9-12   more than 60 %
    10  than
    11  60
    12  %
    13  of
    14  the
           coref: IDENT        20996 14-17  the whole country 's
    15  whole
    16  country
           sense: country-n.3
    17  's
    18  medicine
           sense: medicine-n.1
    19  sales
           sense: sale-n.1
           prop:  sale.01
            n          * -> 19:0, sales
            ARG1       * -> 18:0, medicine
    20  revenue
           sense: revenue-n.1
    21  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    At the same time, 3-5 % of each enterprise's annual sales revenue will be used for the research and development of new
    medicines.

Treebanked sentence:
--------------------
    At the same time , 3 - 5 % of each enterprise 's annual sales revenue will be used *-13 for the research and development
    of new medicines .

Tree:
-----
    (TOP (S (PP-TMP (IN At)
                    (NP (DT the)
                        (JJ same)
                        (NN time)))
            (, ,)
            (NP-SBJ-13 (NP (QP (CD 3)
                               (SYM -)
                               (CD 5))
                           (NN %))
                       (PP (IN of)
                           (NP (NP (DT each)
                                   (NN enterprise)
                                   (POS 's))
                               (JJ annual)
                               (NNS sales)
                               (NN revenue))))
            (VP (MD will)
                (VP (VB be)
                    (VP (VBN used)
                        (NP (-NONE- *-13))
                        (PP-PRP (IN for)
                                (NP (NP (DT the)
                                        (NN research)
                                        (CC and)
                                        (NN development))
                                    (PP (IN of)
                                        (NP (JJ new)
                                            (NNS medicines))))))))
            (. .)))

Leaves:
-------
    0   At
    1   the
    2   same
    3   time
           sense: time-n.12
    4   ,
    5   3
           name:  PERCENT            5-8    3 - 5 %
    6   -
    7   5
    8   %
    9   of
    10  each
    11  enterprise
    12  's
    13  annual
    14  sales
           sense: sale-n.1
    15  revenue
           sense: revenue-n.1
    16  will
    17  be
    18  used
           sense: use-v.3
           prop:  use.01
            v          * -> 18:0, used
            ARGM-TMP   * -> 0:1,  At the same time
            ARGM-MOD   * -> 16:0, will
            ARG1       * -> 19:0, *-13 -> 5:3, 3 - 5 % of each enterprise 's annual sales revenue
            ARG2       * -> 20:1, for the research and development of new medicines
    19  *-13
    20  for
    21  the
    22  research
           sense: research-n.1
    23  and
    24  development
    25  of
    26  new
    27  medicines
           sense: medicine-n.1
    28  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    This official said that, at the same time, the State should also guide foreign capital to invest in new technologies,
    new products and medicine projects in the Midwest area, to give impetus to national medicine enterprises to improve
    products ' technical content and enhance competitiveness in the international market.

Treebanked sentence:
--------------------
    This official said that , at the same time , the State should also guide foreign capital to invest in new technologies ,
    new products and medicine projects in the Midwest area , to give impetus to national medicine enterprises *PRO* to
    improve products ' technical content and enhance competitiveness in the international market .

Tree:
-----
    (TOP (S (NP-SBJ (DT This)
                    (NN official))
            (VP (VBD said)
                (SBAR (IN that)
                      (S (PP-TMP (, ,)
                                 (IN at)
                                 (NP (DT the)
                                     (JJ same)
                                     (NN time))
                                 (, ,))
                         (NP-SBJ (DT the)
                                 (NN State))
                         (VP (MD should)
                             (ADVP (RB also))
                             (VP (VB guide)
                                 (S (NP-SBJ (JJ foreign)
                                            (NN capital))
                                    (VP (VP (TO to)
                                            (VP (VB invest)
                                                (PP-CLR (IN in)
                                                        (NP (NP (JJ new)
                                                                (NNS technologies))
                                                            (, ,)
                                                            (NP (JJ new)
                                                                (NNS products))
                                                            (CC and)
                                                            (NP (NN medicine)
                                                                (NNS projects))))
                                                (PP-LOC (IN in)
                                                        (NP (DT the)
                                                            (NNP Midwest)
                                                            (NN area)))))
                                        (, ,)
                                        (VP (TO to)
                                            (VP (VB give)
                                                (NP (NN impetus))
                                                (PP-DTV (IN to)
                                                        (NP (JJ national)
                                                            (NN medicine)
                                                            (NNS enterprises)))
                                                (S-PRP (NP-SBJ (-NONE- *PRO*))
                                                       (VP (TO to)
                                                           (VP (VP (VB improve)
                                                                   (NP (NP (NNS products)
                                                                           (POS '))
                                                                       (JJ technical)
                                                                       (NN content)))
                                                               (CC and)
                                                               (VP (VB enhance)
                                                                   (NP (NP (NN competitiveness))
                                                                       (PP-LOC (IN in)
                                                                               (NP (DT the)
                                                                                   (JJ international)
                                                                                   (NN market)))))))))))))))))
            (. .)))

Leaves:
-------
    0   This
           coref: IDENT        21012 0-1    This official
    1   official
           sense: official-n.1
    2   said
           sense: say-v.1
           prop:  say.01
            v          * -> 2:0,  said
            ARG0       * -> 0:1,  This official
            ARG1       * -> 3:1,  that , at the same time , the State should also guide foreign capital to invest in new
                                  technologies , new products and medicine projects in the Midwest area , to give
                                  impetus to national medicine enterprises *PRO* to improve products ' technical content
                                  and enhance competitiveness in the international market
    3   that
    4   ,
    5   at
    6   the
    7   same
    8   time
           sense: time-n.12
    9   ,
    10  the
    11  State
           sense: state-n.2
           name:  ORG                11-11  State
    12  should
    13  also
    14  guide
           sense: guide-v.2
           prop:  guide.01
            v          * -> 14:0, guide
            ARGM-TMP   * -> 4:1,  , at the same time ,
            ARG0       * -> 10:1, the State
            ARGM-MOD   * -> 12:0, should
            ARGM-DIS   * -> 13:1, also
            ARG1       * -> 15:2, foreign capital to invest in new technologies , new products and medicine projects in
                                  the Midwest area , to give impetus to national medicine enterprises *PRO* to improve
                                  products ' technical content and enhance competitiveness in the international market
    15  foreign
    16  capital
           sense: capital-n.1
    17  to
    18  invest
           sense: invest-v.1
           prop:  invest.01
            v          * -> 18:0, invest
            ARG0       * -> 15:1, foreign capital
            ARG2       * -> 19:1, in new technologies , new products and medicine projects
            ARGM-LOC   * -> 28:1, in the Midwest area
            ARGM-PRP   * -> 33:1, to give impetus to national medicine enterprises *PRO* to improve products ' technical
                                  content and enhance competitiveness in the international market
    19  in
    20  new
    21  technologies
           sense: technology-n.1
    22  ,
    23  new
    24  products
           sense: product-n.1
    25  and
    26  medicine
           sense: medicine-n.1
    27  projects
           sense: project-n.1
    28  in
    29  the
    30  Midwest
           name:  LOC                30-30  Midwest
    31  area
           sense: area-n.1
    32  ,
    33  to
    34  give
           sense: give-v.4
           prop:  give.01
            v          * -> 34:0, give
            ARG0       * -> 15:1, foreign capital
            ARG1       * -> 35:1, impetus
            ARG2       * -> 36:1, to national medicine enterprises
            ARGM-PRP   * -> 40:2, *PRO* to improve products ' technical content and enhance competitiveness in the
                                  international market
    35  impetus
           sense: impetus-n.1
    36  to
    37  national
    38  medicine
           sense: medicine-n.1
    39  enterprises
    40  *PRO*
    41  to
    42  improve
           sense: improve-v.1
           prop:  improve.01
            v          * -> 42:0, improve
            ARG0       * -> 40:0, *PRO*
            ARG1       * -> 43:2, products ' technical content
            LINK-PCR   * -> 37:1, national medicine enterprises
                       * -> 40:0, *PRO*
    43  products
           sense: product-n.1
    44  '
    45  technical
    46  content
           sense: content-n.1
    47  and
    48  enhance
           sense: enhance-v.1
           prop:  enhance.01
            v          * -> 48:0, enhance
            ARG0       * -> 40:0, *PRO*
            ARG1       * -> 49:2, competitiveness in the international market
            LINK-PCR   * -> 37:1, national medicine enterprises
                       * -> 40:0, *PRO*
    49  competitiveness
    50  in
    51  the
    52  international
    53  market
           sense: market-n.1
    54  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    China now has about 3,500 pharmaceutical enterprises, which produce 1,350 kinds of medicines used as raw materials and
    4,000 kinds of Chinese herbal medicines each year, and is the second largest producing and exporting country of
    medicines used as raw materials, second only to America.

Treebanked sentence:
--------------------
    China now has about 3,500 pharmaceutical enterprises , which *T*-14 produce 1,350 kinds of medicines used * as raw
    materials and 4,000 kinds of Chinese herbal medicines each year , and is the second largest producing and exporting
    country of medicines used * as raw materials , *PRO* second only to America .

Tree:
-----
    (TOP (S (NP-SBJ (NNP China))
            (ADVP-TMP (RB now))
            (VP (VBZ has)
                (NP (NP (QP (IN about)
                            (CD 3,500))
                        (JJ pharmaceutical)
                        (NNS enterprises))
                    (, ,)
                    (SBAR (WHNP-14 (WDT which))
                          (S (NP-SBJ (-NONE- *T*-14))
                             (VP (VBP produce)
                                 (NP (NP (NP (CD 1,350)
                                             (NNS kinds))
                                         (PP (IN of)
                                             (NP (NP (NNS medicines))
                                                 (VP (VBN used)
                                                     (NP (-NONE- *))
                                                     (PP-CLR (IN as)
                                                             (NP (JJ raw)
                                                                 (NNS materials)))))))
                                     (CC and)
                                     (NP (NP (CD 4,000)
                                             (NNS kinds))
                                         (PP (IN of)
                                             (NP (JJ Chinese)
                                                 (JJ herbal)
                                                 (NNS medicines)))))
                                 (NP-TMP (DT each)
                                         (NN year)))))))
            (, ,)
            (CC and)
            (VP (VBZ is)
                (NP-PRD (NP (DT the)
                            (ADJP (RB second)
                                  (JJS largest))
                            (ADJP (VBG producing)
                                  (CC and)
                                  (VBG exporting))
                            (NN country))
                        (PP (IN of)
                            (NP (NP (NNS medicines))
                                (VP (VBN used)
                                    (NP (-NONE- *))
                                    (PP-CLR (IN as)
                                            (NP (JJ raw)
                                                (NNS materials)))))))
                (, ,)
                (S-ADV (NP-SBJ (-NONE- *PRO*))
                       (ADJP-PRD (JJ second)
                                 (PP (ADVP (RB only))
                                     (IN to)
                                     (NP (NNP America))))))
            (. .)))

Leaves:
-------
    0   China
           coref: IDENT        20996 0-0    China
           name:  GPE                0-0    China
    1   now
    2   has
           sense: have-v.1
           prop:  have.03
            v          * -> 2:0,  has
            ARG0       * -> 0:1,  China
            ARGM-TMP   * -> 1:1,  now
            ARG1       * -> 3:3,  about 3,500 pharmaceutical enterprises , which *T*-14 produce 1,350 kinds of medicines
                                  used * as raw materials and 4,000 kinds of Chinese herbal medicines each year
    3   about
    4   3,500
           name:  CARDINAL           4-4    3,500
    5   pharmaceutical
    6   enterprises
    7   ,
    8   which
    9   *T*-14
    10  produce
           sense: produce-v.1
           prop:  produce.01
            v          * -> 10:0, produce
            ARG0       * -> 9:0,  *T*-14 -> 8:1, which
            ARG1       * -> 11:3, 1,350 kinds of medicines used * as raw materials and 4,000 kinds of Chinese herbal
                                  medicines
            ARGM-TMP   * -> 27:1, each year
            LINK-SLC   * -> 3:2,  about 3,500 pharmaceutical enterprises
                       * -> 9:0,  *T*-14 -> 8:1, which
    11  1,350
           name:  CARDINAL           11-11  1,350
    12  kinds
    13  of
    14  medicines
           sense: medicine-n.1
    15  used
           sense: use-v.1
           prop:  use.01
            v          * -> 15:0, used
            ARG1       * -> 16:0, *
            ARG2       * -> 17:1, as raw materials
            LINK-PCR   * -> 14:1, medicines
                       * -> 16:0, *
    16  *
    17  as
    18  raw
    19  materials
           sense: material-n.2
    20  and
    21  4,000
           name:  CARDINAL           21-21  4,000
    22  kinds
    23  of
    24  Chinese
           name:  NORP               24-24  Chinese
    25  herbal
    26  medicines
           sense: medicine-n.1
    27  each
    28  year
    29  ,
    30  and
    31  is
           sense: be-v.2
    32  the
    33  second
           name:  ORDINAL            33-33  second
    34  largest
    35  producing
           prop:  produce.01
            v          * -> 35:0, producing
            ARG0       * -> 38:0, country
    36  and
    37  exporting
           prop:  export.01
            v          * -> 37:0, exporting
            ARG0       * -> 38:0, country
            ARG1       * -> 39:1, of medicines used * as raw materials
    38  country
           sense: country-n.3
    39  of
    40  medicines
           sense: medicine-n.1
    41  used
           sense: use-v.1
           prop:  use.01
            v          * -> 41:0, used
            ARG1       * -> 42:0, *
            ARG2       * -> 43:1, as raw materials
            LINK-PCR   * -> 40:1, medicines
                       * -> 42:0, *
    42  *
    43  as
    44  raw
    45  materials
           sense: material-n.2
    46  ,
    47  *PRO*
    48  second
           name:  ORDINAL            48-48  second
    49  only
    50  to
    51  America
           coref: IDENT        21089 51-51  America
           name:  GPE                51-51  America
    52  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But due to science and technology content being low, the product's sales price on the international market is 20-30 %
    lower than the normal price, and can only return more than 1 billion US dollars in foreign currency each year.

Treebanked sentence:
--------------------
    But due to science and technology content being low , the product 's sales price on the international market is 20 - 30
    % lower than the normal price , and can only return more than 1 billion US dollars in foreign currency each year .

Tree:
-----
    (TOP (S (CC But)
            (PP-PRP (IN due)
                    (IN to)
                    (S-NOM (NP-SBJ (NML (NN science)
                                        (CC and)
                                        (NN technology))
                                   (NN content))
                           (VP (VBG being)
                               (ADJP-PRD (NN low)))))
            (, ,)
            (NP-SBJ (NP (NP (DT the)
                            (NN product)
                            (POS 's))
                        (NNS sales)
                        (NN price))
                    (PP (IN on)
                        (NP (DT the)
                            (JJ international)
                            (NN market))))
            (VP (VP (VBZ is)
                    (ADJP-PRD (ADJP (NP (QP (CD 20)
                                            (SYM -)
                                            (CD 30))
                                        (NN %))
                                    (JJR lower))
                              (PP (IN than)
                                  (NP (DT the)
                                      (JJ normal)
                                      (NN price)))))
                (, ,)
                (CC and)
                (VP (MD can)
                    (ADVP (RB only))
                    (VP (VB return)
                        (NP (NP (QP (JJR more)
                                    (IN than)
                                    (CD 1)
                                    (CD billion))
                                (NNP US)
                                (NNS dollars))
                            (PP (IN in)
                                (NP (JJ foreign)
                                    (NN currency))))
                        (NP-TMP (DT each)
                                (NN year)))))
            (. .)))

Leaves:
-------
    0   But
    1   due
    2   to
    3   science
           sense: science-n.1
    4   and
    5   technology
           sense: technology-n.1
    6   content
           sense: content-n.2
    7   being
           sense: be-v.1
    8   low
    9   ,
    10  the
    11  product
           sense: product-n.1
    12  's
    13  sales
           sense: sale-n.1
    14  price
           sense: price-n.1
    15  on
    16  the
    17  international
    18  market
           sense: market-n.1
    19  is
           sense: be-v.1
    20  20
           name:  PERCENT            20-23  20 - 30 %
    21  -
    22  30
    23  %
    24  lower
    25  than
    26  the
    27  normal
    28  price
           sense: price-n.1
    29  ,
    30  and
    31  can
    32  only
    33  return
           sense: return-v.2
           prop:  return.02
            v          * -> 33:0, return
            ARGM-DIS   * -> 0:0,  But
            ARGM-CAU   * -> 1:1,  due to science and technology content being low
            ARG1       * -> 10:3, the product 's sales price on the international market
            ARGM-MOD   * -> 31:0, can
            ARGM-ADV   * -> 32:1, only
            ARG1       * -> 34:3, more than 1 billion US dollars in foreign currency
            ARGM-ADV   * -> 43:1, each year
    34  more
    35  than
    36  1
        !  name:  MONEY              36-39  1 billion US dollars
    37  billion
    38  US
    39  dollars
    40  in
    41  foreign
    42  currency
           sense: currency-n.5
    43  each
    44  year
    45  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    While in 1996, importing pharmaceutical preparations alone consumed funds surpassing 1.1 billion US dollars in China.

Treebanked sentence:
--------------------
    While *PRO* in 1996 , *PRO* importing pharmaceutical preparations alone consumed funds surpassing 1.1 billion US dollars
    in China .

Tree:
-----
    (TOP (S (SBAR-ADV (IN While)
                      (S (NP-SBJ (-NONE- *PRO*))
                         (PP-TMP-PRD (IN in)
                                     (NP (CD 1996)))))
            (, ,)
            (S-NOM-SBJ (NP-SBJ (-NONE- *PRO*))
                       (VP (VBG importing)
                           (NP (JJ pharmaceutical)
                               (NNS preparations))
                           (ADVP (RB alone))))
            (VP (VBD consumed)
                (NP (NP (NNS funds))
                    (VP (VBG surpassing)
                        (NP (QP (CD 1.1)
                                (CD billion))
                            (NNP US)
                            (NNS dollars))))
                (PP-LOC (IN in)
                        (NP (NNP China))))
            (. .)))

Leaves:
-------
    0   While
    1   *PRO*
    2   in
    3   1996
           name:  DATE               3-3    1996
    4   ,
    5   *PRO*
    6   importing
           sense: import-v.1
           prop:  import.01
            v          * -> 6:0,  importing
            ARG0       * -> 5:0,  *PRO*
            ARG1       * -> 7:1,  pharmaceutical preparations
            ARGM-ADV   * -> 9:1,  alone
    7   pharmaceutical
    8   preparations
           sense: preparation-n.2
    9   alone
    10  consumed
           sense: consume-v.2
           prop:  consume.01
            v          * -> 10:0, consumed
            ARGM-TMP   * -> 0:1,  While *PRO* in 1996
            ARG0       * -> 5:2,  *PRO* importing pharmaceutical preparations alone
            ARG1       * -> 11:2, funds surpassing 1.1 billion US dollars
            ARGM-LOC   * -> 17:1, in China
    11  funds
           sense: fund-n.1
    12  surpassing
           prop:  surpass.01
            v          * -> 12:0, surpassing
            ARG0       * -> 11:1, funds
            ARG1       * -> 13:2, 1.1 billion US dollars
    13  1.1
           name:  MONEY              13-16  1.1 billion US dollars
    14  billion
    15  US
    16  dollars
    17  in
    18  China
           coref: IDENT        20996 18-18  China
           name:  GPE                18-18  China
    19  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Now, in China, there are less than 3,000 full time personnel engaging in the research of innovated medicines, only
    corresponding to personnel on the regular payroll of the research department of Merck Pharmaceutical Company of the US.

Treebanked sentence:
--------------------
    Now , in China , there are less than 3,000 full time personnel engaging in the research of innovated medicines , *PRO*
    only corresponding to personnel on the regular payroll of the research department of Merck Pharmaceutical Company of the
    US .

Tree:
-----
    (TOP (S (ADVP-TMP (RB Now))
            (, ,)
            (PP-LOC (IN in)
                    (NP (NNP China)))
            (, ,)
            (NP-SBJ (EX there))
            (VP (VBP are)
                (NP-PRD (NP (QP (JJR less)
                                (IN than)
                                (CD 3,000))
                            (ADJP (JJ full)
                                  (NN time))
                            (NNS personnel))
                        (VP (VBG engaging)
                            (PP-CLR (IN in)
                                    (NP (NP (DT the)
                                            (NN research))
                                        (PP (IN of)
                                            (NP (VBN innovated)
                                                (NNS medicines)))))))
                (, ,)
                (S-ADV (NP-SBJ (-NONE- *PRO*))
                       (ADVP (RB only))
                       (VP (VBG corresponding)
                           (PP-CLR (IN to)
                                   (NP (NP (NNS personnel))
                                       (PP (IN on)
                                           (NP (NP (DT the)
                                                   (JJ regular)
                                                   (NN payroll))
                                               (PP (IN of)
                                                   (NP (NP (DT the)
                                                           (NN research)
                                                           (NN department))
                                                       (PP (IN of)
                                                           (NP (NP (NNP Merck)
                                                                   (NNP Pharmaceutical)
                                                                   (NNP Company))
                                                               (PP (IN of)
                                                                   (NP (DT the)
                                                                       (NNP US))))))))))))))
            (. .)))

Leaves:
-------
    0   Now
    1   ,
    2   in
    3   China
           coref: IDENT        20996 3-3    China
           name:  GPE                3-3    China
    4   ,
    5   there
    6   are
           sense: be-v.3
    7   less
           name:  CARDINAL           7-9    less than 3,000
    8   than
    9   3,000
    10  full
    11  time
           sense: time-n.3
    12  personnel
    13  engaging
           sense: engage-v.1
           prop:  engage.01
            v          * -> 13:0, engaging
            ARG0       * -> 7:2,  less than 3,000 full time personnel
            ARG2       * -> 14:1, in the research of innovated medicines
    14  in
    15  the
    16  research
           sense: research-n.1
    17  of
    18  innovated
           prop:  innovate.01
            v          * -> 18:0, innovated
            ARG1       * -> 19:0, medicines
    19  medicines
           sense: medicine-n.1
    20  ,
    21  *PRO*
    22  only
    23  corresponding
           sense: correspond-v.1
    24  to
    25  personnel
    26  on
    27  the
    28  regular
    29  payroll
    30  of
    31  the
    32  research
    33  department
    34  of
    35  Merck
           name:  ORG                35-37  Merck Pharmaceutical Company
    36  Pharmaceutical
    37  Company
    38  of
    39  the
           coref: IDENT        21089 39-40  the US
    40  US
           name:  GPE                40-40  US
    41  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Experts urge that China's pharmaceutical industry should change methods of focusing on the production of medicines used
    as raw materials, while paying less attention to development of preparations, and catching up with development trends of
    the global pharmaceutical industry as soon as possible.

Treebanked sentence:
--------------------
    Experts urge that China 's pharmaceutical industry should change methods of *PRO* focusing on the production of
    medicines used * as raw materials , while *PRO*-16 paying less attention to development of preparations , and catching
    up with development trends of the global pharmaceutical industry as soon as possible .

Tree:
-----
    (TOP (S (NP-SBJ (NNS Experts))
            (VP (VBP urge)
                (SBAR (IN that)
                      (S (NP-SBJ-16 (NP (NNP China)
                                        (POS 's))
                                    (JJ pharmaceutical)
                                    (NN industry))
                         (VP (MD should)
                             (VP (VB change)
                                 (NP (NP (NNS methods))
                                     (PP (IN of)
                                         (S-NOM (NP-SBJ (-NONE- *PRO*))
                                                (VP (VBG focusing)
                                                    (PP-CLR (IN on)
                                                            (NP (NP (DT the)
                                                                    (NN production))
                                                                (PP (IN of)
                                                                    (NP (NP (NNS medicines))
                                                                        (VP (VBN used)
                                                                            (NP (-NONE- *))
                                                                            (PP-CLR (IN as)
                                                                                    (NP (JJ raw)
                                                                                        (NNS materials))))))))))))
                                 (, ,)
                                 (SBAR-TMP (IN while)
                                           (S (NP-SBJ (-NONE- *PRO*-16))
                                              (VP (VP (VBG paying)
                                                      (NP (NP (JJR less)
                                                              (NN attention))
                                                          (PP (IN to)
                                                              (NP (NP (NN development))
                                                                  (PP (IN of)
                                                                      (NP (NNS preparations)))))))
                                                  (, ,)
                                                  (CC and)
                                                  (VP (VBG catching)
                                                      (PRT (RP up))
                                                      (PP-CLR (IN with)
                                                              (NP (NP (NN development)
                                                                      (NNS trends))
                                                                  (PP (IN of)
                                                                      (NP (DT the)
                                                                          (JJ global)
                                                                          (JJ pharmaceutical)
                                                                          (NN industry)))))
                                                      (ADVP-TMP (ADVP (RB as)
                                                                      (RB soon))
                                                                (PP (IN as)
                                                                    (FRAG (ADJP (JJ possible))))))))))))))
            (. .)))

Leaves:
-------
    0   Experts
    1   urge
           sense: urge-v.2
           prop:  urge.01
            v          * -> 1:0,  urge
            ARG0       * -> 0:1,  Experts
            ARG2       * -> 2:1,  that China 's pharmaceutical industry should change methods of *PRO* focusing on the
                                  production of medicines used * as raw materials , while *PRO*-16 paying less attention
                                  to development of preparations , and catching up with development trends of the global
                                  pharmaceutical industry as soon as possible
    2   that
    3   China
           coref: IDENT        20996 3-4    China 's
           coref: IDENT        20995 3-6    China 's pharmaceutical industry
           name:  GPE                3-3    China
    4   's
    5   pharmaceutical
    6   industry
           sense: industry-n.1
    7   should
    8   change
           sense: change-v.1
           prop:  change.01
            v          * -> 8:0,  change
            ARG0       * -> 25:0, *PRO*-16 -> 3:2, China 's pharmaceutical industry
            ARGM-MOD   * -> 7:0,  should
            ARG1       * -> 9:2,  methods of *PRO* focusing on the production of medicines used * as raw materials
            ARGM-TMP   * -> 24:1, while *PRO*-16 paying less attention to development of preparations , and catching up
                                  with development trends of the global pharmaceutical industry as soon as possible
    9   methods
    10  of
    11  *PRO*
    12  focusing
           prop:  focus.01
            v          * -> 12:0, focusing
            ARG0       * -> 11:0, *PRO*
            ARG2       * -> 13:1, on the production of medicines used * as raw materials
    13  on
    14  the
    15  production
           sense: production-n.6
           prop:  production.01
            n          * -> 15:0, production
            ARG1       * -> 16:1, of medicines used * as raw materials
    16  of
    17  medicines
           sense: medicine-n.1
    18  used
           sense: use-v.1
           prop:  use.01
            v          * -> 18:0, used
            ARG1       * -> 19:0, *
            ARG2       * -> 20:1, as raw materials
            LINK-PCR   * -> 17:1, medicines
                       * -> 19:0, *
    19  *
    20  as
    21  raw
    22  materials
           sense: material-n.2
    23  ,
    24  while
    25  *PRO*-16
    26  paying
           sense: pay-v.2
           prop:  pay.01
            v          * -> 26:0, paying
            ARG0       * -> 25:0, *PRO*-16 -> 3:2, China 's pharmaceutical industry
            ARG1       * -> 27:1, less attention
            ARG2       * -> 29:1, to development of preparations
    27  less
    28  attention
           sense: attention-n.1
    29  to
    30  development
    31  of
    32  preparations
           sense: preparation-n.2
    33  ,
    34  and
    35  catching
           sense: catch-v.4
           prop:  catch.04
            v          * -> 35:0, catching
                         -> 36:1, up
            ARG1       * -> 25:0, *PRO*-16 -> 3:2, China 's pharmaceutical industry
            ARG2       * -> 37:1, with development trends of the global pharmaceutical industry
            ARGM-TMP   * -> 45:2, as soon as possible
    36  up
    37  with
    38  development
    39  trends
           sense: trend-n.2
    40  of
    41  the
    42  global
    43  pharmaceutical
    44  industry
           sense: industry-n.1
    45  as
    46  soon
    47  as
    48  possible
    49  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    It was learned that, the national project of new medicines and industrialized development, jointly promoted by
    departments of the State Science Commission, the Ministry of Public Health, the State Pharmaceutical Administration
    Bureau, etc., is now being implemented.

Treebanked sentence:
--------------------
    It *EXP*-22 was learned *-17 that , the national project of new medicines and industrialized development , jointly
    promoted * by departments of the State Science Commission , the Ministry of Public Health , the State Pharmaceutical
    Administration Bureau , etc. , is now being implemented *-18 .

Tree:
-----
    (TOP (S (NP-SBJ-17 (NP (PRP It))
                       (SBAR (-NONE- *EXP*-22)))
            (VP (VBD was)
                (VP (VBN learned)
                    (NP (-NONE- *-17))
                    (SBAR-22 (IN that)
                             (, ,)
                             (S (NP-SBJ-18 (NP (NP (DT the)
                                                   (JJ national)
                                                   (NN project))
                                               (PP (IN of)
                                                   (NP (NP (JJ new)
                                                           (NNS medicines))
                                                       (CC and)
                                                       (NP (VBN industrialized)
                                                           (NN development)))))
                                           (VP (, ,)
                                               (ADVP (RB jointly))
                                               (VBN promoted)
                                               (NP (-NONE- *))
                                               (PP (IN by)
                                                   (NP-LGS (NP (NNS departments))
                                                           (PP (IN of)
                                                               (NP (NP (DT the)
                                                                       (NNP State)
                                                                       (NNP Science)
                                                                       (NNP Commission))
                                                                   (, ,)
                                                                   (NP (NP (DT the)
                                                                           (NNP Ministry))
                                                                       (PP (IN of)
                                                                           (NP (NNP Public)
                                                                               (NNP Health))))
                                                                   (, ,)
                                                                   (NP (DT the)
                                                                       (NNP State)
                                                                       (NML (NNP Pharmaceutical)
                                                                            (NNP Administration))
                                                                       (NNP Bureau))
                                                                   (, ,)
                                                                   (ADVP-ETC (FW etc.))))))
                                               (, ,)))
                                (VP (VBZ is)
                                    (ADVP-TMP (RB now))
                                    (VP (VBG being)
                                        (VP (VBN implemented)
                                            (NP (-NONE- *-18)))))))))
            (. .)))

Leaves:
-------
    0   It
    1   *EXP*-22
    2   was
    3   learned
           sense: learn-v.2
           prop:  learn.01
            v          * -> 3:0,  learned
            ARG1       * -> 1:0,  *EXP*-22 -> 5:1, that , the national project of new medicines and industrialized
                                                   development , jointly promoted * by departments of the State Science
                                                   Commission , the Ministry of Public Health , the State Pharmaceutical
                                                   Administration Bureau , etc. , is now being implemented *-18
    4   *-17
    5   that
    6   ,
    7   the
    8   national
    9   project
           sense: project-n.1
    10  of
    11  new
    12  medicines
           sense: medicine-n.1
    13  and
    14  industrialized
           prop:  industrialize.01
            v          * -> 14:0, industrialized
            ARG1       * -> 15:0, development
    15  development
    16  ,
    17  jointly
    18  promoted
           prop:  promote.02
            v          * -> 18:0, promoted
            ARG1       * -> 19:0, *
            ARGM-MNR   * -> 17:1, jointly
            ARG0       * -> 20:1, by departments of the State Science Commission , the Ministry of Public Health , the
                                  State Pharmaceutical Administration Bureau , etc.
            LINK-PCR   * -> 7:2,  the national project of new medicines and industrialized development
                       * -> 19:0, *
    19  *
    20  by
    21  departments
           sense: department-n.1
    22  of
    23  the
           name:  ORG                23-26  the State Science Commission
    24  State
    25  Science
    26  Commission
    27  ,
    28  the
           name:  ORG                28-32  the Ministry of Public Health
    29  Ministry
    30  of
    31  Public
    32  Health
    33  ,
    34  the
           coref: IDENT        21014 34-38  the State Pharmaceutical Administration Bureau
           name:  ORG                34-38  the State Pharmaceutical Administration Bureau
    35  State
    36  Pharmaceutical
    37  Administration
    38  Bureau
    39  ,
    40  etc.
    41  ,
    42  is
    43  now
    44  being
    45  implemented
           sense: implement-v.1
           prop:  implement.01
            v          * -> 45:0, implemented
            ARGM-TMP   * -> 43:1, now
            ARG1       * -> 46:0, *-18 -> 7:3, the national project of new medicines and industrialized development ,
                                               jointly promoted * by departments of the State Science Commission , the
                                               Ministry of Public Health , the State Pharmaceutical Administration
                                               Bureau , etc. ,
            LINK-PCR   * -> 46:0, *-18 -> 7:3, the national project of new medicines and industrialized development ,
                                               jointly promoted * by departments of the State Science Commission , the
                                               Ministry of Public Health , the State Pharmaceutical Administration
                                               Bureau , etc. ,
                       * -> 46:0, *-18 -> 7:3, the national project of new medicines and industrialized development ,
                                               jointly promoted * by departments of the State Science Commission , the
                                               Ministry of Public Health , the State Pharmaceutical Administration
                                               Bureau , etc. ,
    46  *-18
    47  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    By the end of this century, ten new patent protected medicines are planned to be developed and five new medicine
    selecting centers, five medication safety assessing centers and five medication clinic experimentation centers will be
    built.

Treebanked sentence:
--------------------
    By the end of this century , ten new patent protected medicines are planned *-19 to be developed *-19 and five new
    medicine selecting centers , five medication safety assessing centers and five medication clinic experimentation centers
    will be built *-21 .

Tree:
-----
    (TOP (S (S (PP-TMP (IN By)
                       (NP (NP (DT the)
                               (NN end))
                           (PP (IN of)
                               (NP (DT this)
                                   (NN century)))))
               (, ,)
               (NP-SBJ-19 (CD ten)
                          (JJ new)
                          (ADJP (NN patent)
                                (VBN protected))
                          (NNS medicines))
               (VP (VBP are)
                   (VP (VBN planned)
                       (S (NP-SBJ (-NONE- *-19))
                          (VP (TO to)
                              (VP (VB be)
                                  (VP (VBN developed)
                                      (NP (-NONE- *-19)))))))))
            (CC and)
            (S (NP-SBJ-21 (NP (CD five)
                              (JJ new)
                              (ADJP (NN medicine)
                                    (VBG selecting))
                              (NNS centers))
                          (, ,)
                          (NP (CD five)
                              (ADJP (NP (NN medication)
                                        (NN safety))
                                    (VBG assessing))
                              (NNS centers))
                          (CC and)
                          (NP (CD five)
                              (NN medication)
                              (NN clinic)
                              (NN experimentation)
                              (NNS centers)))
               (VP (MD will)
                   (VP (VB be)
                       (VP (VBN built)
                           (NP (-NONE- *-21))))))
            (. .)))

Leaves:
-------
    0   By
    1   the
           name:  DATE               1-5    the end of this century
    2   end
           sense: end-n.3
           prop:  end.01
            n          * -> 2:0,  end
            ARG1       * -> 3:1,  of this century
    3   of
    4   this
    5   century
    6   ,
    7   ten
           name:  CARDINAL           7-7    ten
    8   new
    9   patent
    10  protected
           prop:  protect.01
            v          * -> 10:0, protected
            ARG3       * -> 9:0,  patent
            ARG1       * -> 11:0, medicines
    11  medicines
           sense: medicine-n.1
    12  are
    13  planned
           sense: plan-v.2
           prop:  plan.01
            v          * -> 13:0, planned
            ARGM-TMP   * -> 0:1,  By the end of this century
            ARG1       * -> 14:2, *-19 to be developed *-19
    14  *-19
    15  to
    16  be
    17  developed
           sense: develop-v.1
           prop:  develop.02
            v          * -> 17:0, developed
            ARG1       * -> 18:0, *-19 -> 7:1, ten new patent protected medicines
            LINK-PCR   * -> 18:0, *-19 -> 7:1, ten new patent protected medicines
                       * -> 18:0, *-19 -> 7:1, ten new patent protected medicines
                       * -> 18:0, *-19 -> 7:1, ten new patent protected medicines
    18  *-19
    19  and
    20  five
           name:  CARDINAL           20-20  five
    21  new
    22  medicine
           sense: medicine-n.1
    23  selecting
           sense: select-v.1
           prop:  select.01
            v          * -> 23:0, selecting
            ARG1       * -> 22:0, medicine
            ARG0       * -> 24:0, centers
    24  centers
           sense: center-n.2
    25  ,
    26  five
           name:  CARDINAL           26-26  five
    27  medication
    28  safety
    29  assessing
           prop:  assess.01
            v          * -> 29:0, assessing
            ARG1       * -> 27:1, medication safety
            ARG0       * -> 30:0, centers
    30  centers
           sense: center-n.2
    31  and
    32  five
           name:  CARDINAL           32-32  five
    33  medication
    34  clinic
    35  experimentation
    36  centers
           sense: center-n.2
    37  will
    38  be
    39  built
           sense: build-v.1
           prop:  build.01
            v          * -> 39:0, built
            ARGM-TMP   * -> 0:1,  By the end of this century
            ARGM-MOD   * -> 37:0, will
            ARG1       * -> 40:0, *-21 -> 20:2, five new medicine selecting centers , five medication safety assessing
                                                centers and five medication clinic experimentation centers
            LINK-PCR   * -> 40:0, *-21 -> 20:2, five new medicine selecting centers , five medication safety assessing
                                                centers and five medication clinic experimentation centers
                       * -> 40:0, *-21 -> 20:2, five new medicine selecting centers , five medication safety assessing
                                                centers and five medication clinic experimentation centers
    40  *-21
    41  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    -LRB-End-RRB-

Treebanked sentence:
--------------------
    -LRB- End -RRB-

Tree:
-----
    (TOP (NP (-LRB- -LRB-)
             (NN End)
             (-RRB- -RRB-)))

Leaves:
-------
    0   -LRB-
    1   End
           sense: end-n.4
    2   -RRB-


========================================================================================================================
Coreference chains for section 0:
---------------------------------

    Chain 20996 (IDENT)
               1.0-1      China 's
               4.14-17    the whole country 's
               7.0-0      China
               9.18-18    China
               10.3-3     China
               11.3-4     China 's

    Chain 20995 (IDENT)
               1.0-3      China 's pharmaceutical enterprises
               1.40-40    their
               11.3-6     China 's pharmaceutical industry

    Chain 21012 (IDENT)
               2.0-7      An official from the State Pharmaceutical Administration Bureau
               6.0-1      This official

    Chain 21014 (IDENT)
               2.3-7      the State Pharmaceutical Administration Bureau
               3.3-7      the State Pharmaceutical Administration Bureau
               12.34-38   the State Pharmaceutical Administration Bureau

    Chain 21016 (IDENT)
               2.13-14    this year
               3.0-1      This year

    Chain 21089 (IDENT)
               7.51-51    America
               10.39-40   the US
